Intellectual Property UK

  • August 12, 2025

    EU Blocks Venture Fund's 'BSV' TM Over Bitcoin Confusion

    European Union officials have refused an application by a Silicon Valley venture fund for a "BSV" trademark, citing a risk of confusion with the acronym of the "Bitcoin Satoshi Vision" cryptocurrency.

  • August 11, 2025

    Merz Asks UPC To Bar Viatris Generic MS Drug

    Pharmaceutical giant Merz has sued generic-drug maker Viatris and asked Europe's patent court for a preliminary injunction as it fights to protect a soon-to-expire patented treatment for multiple sclerosis. 

  • August 11, 2025

    Nvidia Faces Another UPC Suit From Supercomputer Biz

    Supercomputer manufacturer ParTec has filed another infringement claim against Nvidia at the Unified Patent Court, seeking to stop the technology titan from selling certain artificial intelligence-powering processors.

  • August 11, 2025

    Warner Bros. Can't Block Rival TM's Use Of 'Big Bang'

    Warner Bros. can't prevent a Belgian production company from registering a trademark for "The Big Bang," after European officials found that the media giant's earlier marks for "The Big Bang Theory" covered unrelated slot machines.

  • August 11, 2025

    Edwards Fends Off Abbott's Heart Valve Patent Challenge

    Edwards has revived its heart valve patent following a challenge from Abbott, convincing a European appeals panel that the patent is no broader than the original filing underpinning its protections.

  • August 08, 2025

    GlaxoSmithKline Will Get $500M In CureVac-Pfizer Patent Deal

    British pharmaceutical company GlaxoSmithKline said Friday it stands to make up to $500 million from settlements between German biotech companies CureVac and BioNTech after their legal disputes were squashed by a merger.

  • August 08, 2025

    Match Beats Rest Of British Telecommunications Patent Suit

    Match.com has defeated the remainder of a lawsuit claiming it infringed a personal profile patent owned by British Telecommunications, saying the last claim at issue didn't pass either prong of the U.S. Supreme Court's Alice test.

  • August 08, 2025

    Fieldfisher Patent Team Joins Casalonga's German Operation

    European IP firm Casalonga has opened a second office in Germany and brought in a team of patent litigation lawyers from Fieldfisher LLP, as it aims to build a strong presence across member countries of the Unified Patent Court.

  • August 08, 2025

    Business As Usual For EPO As Top Board Mulls Best Practice

    The European Patent Office won't pause examination and opposition proceedings while its highest judicial authority considers the extent that parties may amend patent claims during these affairs.

  • August 08, 2025

    BAE Unit Challenges Drone Patent In Infringement Case

    A BAE Systems unit has denied infringing a drone-maker's patent by selling heavy lift drones for rapid aid delivery, arguing that its rival's technology didn't deserve to be protected in the first place. 

  • August 08, 2025

    Calvin Klein Slashes Chinese Co.'s 'CKA' UK TM Bid

    Calvin Klein has persuaded U.K. officials to block the majority of a Chinese company's "CKA" trademark application, proving there is a risk of confusion with its famous CK branding.

  • August 08, 2025

    FujiFilm Can't Overturn Case For Chemical Container Patent

    A Siemens unit has convinced European officials that Fujifilm's chemical arm doesn't deserve a patent for a container that holds laboratory chemicals because a previous invention had already revealed a 3D structured opening for ease of use.

  • August 08, 2025

    UK Litigation Roundup: Here's What You Missed In London

    This past week in London has seen the U.S. Securities and Exchange Commission target a British investor over a $10 million microcap fraud scheme, Merck Sharp & Dohme move against Halozyme Inc. following a recent clash over its patented cancer medicine, and Birmingham City Council sue a school minibus operator years after ending its contract over DBS check failures. Here, Law360 looks at these and other new claims in the U.K. 

  • August 07, 2025

    BioNTech's Acquisition Of CureVac Ends COVID Vax Case

    CureVac's case alleging Pfizer and BioNTech infringed patents related to messenger RNA technology is set to be dismissed after BioNTech announced in June that it would be acquiring CureVac, canceling what would have been the first-ever trial over COVID-19 vaccine patents in the U.S.

  • August 07, 2025

    Axel Springer Gets 2nd Shot To Prove Ad Blocker Infringes IP

    Axel Springer has won a second shot at proving that an ad blocker is infringing its copyright by modifying its computer program, after a federal court overturned an earlier ruling that influencing program flow didn't alter underlying software.

  • August 07, 2025

    French Orgs. Can't Get Unitary Protection For Biotelemetry IP

    France's largest research body has failed in its bid to extend protection for a small ingestible device that collects physiological data because the Unified Patent Court found that the three owners had missed the deadline to fix a key issue with its application.

  • August 07, 2025

    Top EU Court To Weigh File-Sharing Copyright Question

    A German court said in a ruling released Thursday that it has asked the European Union's top judicial body to clarify whether sharing a recording through a hyperlink counts as making it publicly available under the bloc's copyright laws.

  • August 07, 2025

    Cosmetics Co. Says Rival Copied LED Face Mask Style

    A British cosmetics company has told a London court that a French competitor infringed its intellectual property rights in the style of a popular LED light-therapy mask.

  • August 07, 2025

    German Car Parts Biz Says UK Rival Copied Brake Calipers

    A German car parts supplier has accused a British competitor of infringing its patents for brake calipers, telling a London court that its opponent has sold products that are "substantial copies" of its own goods.

  • August 06, 2025

    Crocs Beats Rival's Bid To Nix Design Through Amazon Sales

    Crocs Inc. has successfully defended itself against a German shoe company's bid to nix one of its footwear designs as a European intellectual property appeals board found that older designs sold on Amazon depicted a sufficiently different clog-style shoe.

  • August 06, 2025

    EU's Anti-Suit Win A Good Omen For China FRAND Complaint

    The World Trade Organization's recent decision to side with the European Union in a battle over Chinese standard essential patents hamstrings a tactic from licensees to bar patent owners from suing in other jurisdictions but bodes well for the bloc's parallel challenge to Beijing's unilateral rate-setting decisions.

  • August 06, 2025

    Infineon Wins Semiconductor IP Clash Against Chinese Rival

    Chipmaker Infineon has won its semiconductor patent fight with a Chinese competitor, persuading a German court to ban its rival's sales of certain products that infringe its patent.

  • August 06, 2025

    Sanofi Pauses Heart Disease Drug Patent Dispute With Amgen

    Sanofi and Regeneron persuaded the Unified Patent Court on Wednesday to pause their clash with Amgen over a patent for a heart disease drug while awaiting the outcome of an appeal in a parallel case.

  • August 06, 2025

    Freshfields-Led Sanofi Wraps Up $470M Vigil Buy

    Sanofi said Wednesday that it has completed the approximately $470 million acquisition of U.S. biotechnology company Vigil Neuroscience, which specializes in neurodegenerative diseases, strengthening the French pharma titan's early-stage medicine pipeline in neurology.

  • August 06, 2025

    IP Crime Unit Seizes Fake Football Merch Worth Over £5M

    A police unit that tackles intellectual property crime has said it has collared almost 68,000 counterfeit football kits since the start of 2025, preventing sales that would have been worth £5.1 million ($6.8 million) if the items were genuine.

Expert Analysis

  • Takeaways On Pre-Action Protocols From UK Patent Ruling

    Author Photo

    The U.K. High Court's recent patent ruling in Add2 Research v. dSpace instructs parties in proper pre-action discussions that avoid breaches of protocol, including how to provide materials in confidence, say Angela Jack and Emily Atherton at EIP.

  • 6 Ways To Guide Applications Under New Patent Classification

    Author Photo

    Intellectual property practitioners can navigate the recently implemented Cooperative Patent Classification system to direct applications to specific prior art units within the U.S. Patent and Trademark Office, avoid especially difficult units, and improve clients' portfolios in newly emerging technologies, say Roberta Young and Brian Michaelis at Seyfarth.

  • Mitigating User Content Risk After EU Copyright Directive

    Author Photo

    As the deadline approaches for member states to implement the European Union’s new copyright directive, which will hold certain online content service providers liable for copyright infringement pertaining to user-uploaded content, companies should have risk-mitigation strategies in place, say attorneys at MoFo.

  • The Pandemic's Bright Spots For Lawyers Who Are Parents

    Author Photo

    The COVID-19 crisis has allowed lawyers to hone remote advocacy strategies and effectively represent clients with minimal travel — abilities that have benefited working parents and should be utilized long after the pandemic is over, says Chelsea Loughran at Wolf Greenfield.

  • ITC Seems Unlikely To Stay Investigations For Parallel IPRs

    Author Photo

    The U.S. International Trade Commission's recent order denying Ocado's attempt to stay a dispute with AutoStore pending resolution of its inter partes review petitions signals that an ITC complainant's patents are effectively shielded from IPR challenges, at least under current Patent Trial and Appeal Board practice, say attorneys at Reichman Jorgensen.

  • A Framework For Evaluating Willingness Of FRAND Licensees

    Author Photo

    As an increasing number of standard-essential patent cases turn on whether a manufacturer is willing to pay a fair, reasonable and nondiscriminatory royalty for SEPs, Jorge Contreras at the University of Utah identifies conduct that typically indicates willingness or unwillingness, as well as conduct that should be viewed as indeterminate.

  • Opinion

    US Should Learn From German Courts Balancing SEP Rights

    Author Photo

    The German high court's recent decision in Sisvel v. Haier set a productive tone in balancing the rights of patentees and implementers in standard-essential patent disputes, and its understanding of negotiation realities should be followed by the U.S., say Cravath's David Kappos, former U.S. Patent and Trademark Office director, and Daniel Etcovitch.

  • Examining EPO's Strict Approach To AI Patent Disclosure

    Author Photo

    Because a recent decision by the European Patent Office Boards of Appeal takes a potentially problematic strict approach to disclosure requirements for machine learning-related patent applications, U.S. applicants filing in the EU should disclose several specific data training sets, says Ronny Amirsehhi at Clifford Chance.

  • ITC Dispute May Lead To PTAB Litigation Strategy Shifts

    Author Photo

    A pending motion to stay the dispute between AutoStore and Ocado at the U.S. International Trade Commission highlights competing timelines of the ITC and Patent Trial and Appeal Board, and has the potential to reshape the typical forum selection strategies for patentees and defense tactics for challengers, say attorneys at Reichman Jorgensen.

  • Opinion

    US Courts Should Adjudicate FRAND Rates On A Global Basis

    Author Photo

    Following the U.K. Supreme Court's recent Unwired Planet v. Huawei decision, U.S. courts should analyze compliance with contracts on fair, reasonable and nondiscriminatory terms by assessing them on a worldwide basis, because global licenses are the only technically and financially sound way to license standard-essential patents, say attorneys at McKool Smith.

  • UK Top Court Ruling May Be Problematic For Global SEP Suits

    Author Photo

    There are several reasons to question the wisdom of the U.K. Supreme Court's recent ruling that English judges have the power to set extraterritorial licensing royalty rates for standard-essential patents, including that it encourages forum shopping, says Thomas Cotter at the University of Minnesota Law School.

  • UK Ruling Shows Global SEP Enforcement Dilemma

    Author Photo

    The U.K. Supreme Court's recent ruling that U.K. judges have the power to set extraterritorial licensing royalty rates for standard-essential patents highlights a problem with global patent enforcement coordination and efficiency that could potentially be solved through the Patent Cooperation Treaty, says Roya Ghafele at Oxfirst.

  • Time To Reassess Your Patent Cooperation Treaty Strategy

    Author Photo

    In light of the trends outlined in the World Intellectual Property Organization's recent annual Patent Cooperation Treaty review, applicants should make decisions on which international search authority to use based on immediate cost, total cost and quality, says Karam Saab at Kilpatrick.

  • German FRAND Decision May Shape Global SEP Landscape

    Author Photo

    The German high court's recent decision that patent owner Sisvel didn't breach its fair, reasonable and nondiscriminatory patent licensing obligations by refusing to grant Haier a license represents a shift in the standard-essential patent landscape in favor of SEP holders' enforcement freedom, say Erik Puknys and Michelle Rice at Finnegan.

  • Sustainable Food Progress May Close Global Regulatory Gap

    Author Photo

    As the need for sustainable food production grows, the European sector will likely align with less stringent U.S. regulatory standards, which will further enable U.S. companies to expand globally and lead to more sophisticated intellectual property strategies in all regions, say Jane Hollywood and Fiona Carter at CMS Legal.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property UK archive.